Vaxart (NASDAQ: VXRT) reported Q1 EPS of $0.02, $0.03 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $39.23 million versus the consensus estimate of $65.5 million.

For earnings history and earnings-related data on Vaxart (VXRT) click here.